SARS-CoV-2-IN-86

SARS-CoV-2-IN-86

• CAS Number: 368866-07-3
• UNSPSC Description: SARS-CoV-2-IN-86 (Compound 2734589) is a dual inhibitor of the methyltransferases nsp14 and nsp16 of SARS-CoV-2. SARS-CoV-2-IN-86 exhibits low toxicity with a LD50 of 700 mg/kg according to toxicity analysis predict[1].
• Target Antigen: SARS-CoV
• Type: Peptides
• Related Pathways: Anti-infection
• Applications: COVID-19-anti-virus
• Field of Research: Infection
• Assay Protocol: https://www.medchemexpress.com/sars-cov-2-in-86.html
• Purity: 99.38
• Solubility: DMSO : 50 mg/mL (ultrasonic;warming;heat to 60°C)
• Smiles: CC(OC(NC1(CCN(CC1)C(OCC2C3=CC=CC=C3C4=CC=CC=C42)=O)C(O)=O)=O)(C)C
• Molecular Weight: 466.534
• References & Citations: [1]Thomas J, et al., Cheminformatics approach to identify andrographolide derivatives as dual inhibitors of methyltransferases (nsp14 and nsp16) of SARS-CoV-2. Sci Rep. 2024 Apr 29;14(1):9801.
• Shipping Conditions: Room Temperature
• Storage Conditions: -20°C, 3 years; 4°C, 2 years (Powder)
• Clinical Information: No Development Reported